The Patent Finder

B3AR Therapeutics, Inc.

Also on record
Records under this name other than the patents B3AR Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Showing 1 to 7 of 7 · Back to B3AR Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 11,691,944Solabegron Zwitterion and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,435,026Solabegron Zwitterion and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,065,922Solabegron Zwitterion and Uses Thereof
Lapsed on the fee record
Ended Sep 4, 2026 · High confidence
Lapsed on the fee recordEnded Sep 4, 2026High confidence
US 7,425,639Process
Term ended
Term ended Dec 26, 2023 · High confidence
Term endedTerm ended Dec 26, 2023High confidence
US 7,034,053Phenethanolamine Derivatives, Compositions, and Their Use as Agonists at Atypical Beta-Adrenoreceptors
Term ended
Term ended Sep 3, 2022 · High confidence
Term endedTerm ended Sep 3, 2022High confidence
US 7,709,677Process of Preparing Arylethanoldiamines
Term ended
Term ended Dec 17, 2021 · High confidence
Term endedTerm ended Dec 17, 2021High confidence
US 6,548,523Process for the Preparation of Arylethanolamine Derivatives Having an Anti-Obesity and Anti-Diabetic Properties
Term ended
Term ended Dec 8, 2020 · High confidence
Term endedTerm ended Dec 8, 2020High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited